dualyx

Technologiepark-Zwijnaarde 94

9052 Gent

BE

dualyx

Foundation date

21/11/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024